.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

In-person and virtual events just for HCPs

SpecialtySee All >

Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Refining Therapy for Chronic Lymphocytic Leukemia

EP. 1: The Risk-Stratifying Factors in CLL

January 12th 2018

EP. 2: CLL: The Risk of Richter's Transformation

January 12th 2018

EP. 3: Deciding on CLL Therapy and When to Treat

January 12th 2018

EP. 4: Therapeutic Approaches for CLL

January 12th 2018

EP. 5: Safety and Efficacy of CLL Treatments

January 12th 2018

EP. 6: Managing Patients With CLL

January 12th 2018

EP. 7: Maintenance and Frontline Therapy in CLL

January 12th 2018

EP. 8: Therapeutic Approaches for R/R CLL

January 12th 2018

EP. 9: Additional Therapies for R/R CLL

January 12th 2018

EP. 10: Combination Therapies in CLL

January 12th 2018

EP. 11: The Use of Novel PI3K Inhibitors in CLL

January 12th 2018

EP. 12: Other Promising Strategies in CLL

January 12th 2018

EP. 13: The Role of Transplant and Future of CLL

January 12th 2018